A clinical trial is a type of research that studies a test or treatment given to people.
A registry is defined as an organization or website that either:
Following the Ministerial Summit on Health Research that took place in Mexico City, Mexico, in November 2004, participants called for the WHO to facilitate the establishment of: "a network of international clinical trial registers to ensure a single point of access and the unambiguous identification of trials".
This was further expanded on during the 58th World Health Assembly in Resolution WHA58.22 that called on the global scientific community, international partners, the private sector, civil society, and other relevant stakeholders to: "establish a voluntary platform to link clinical trials registers in order to ensure a single point of access and the unambiguous identification of trials with a view to enhancing access to information by patients, families, patient groups and others".
NPCTR is a web-based registry with worldwide free and open access to researchers, clinicians and the general public.
Any investigator from Nepal or overseas can register a clinical trial with the NPCTR. The responsibility for registering a trial lies with the principal investigator or principal sponsor of the trial. For multi-center trials, the principal investigator or sponsor should take responsibility for registration.
WHO/ICTRP mandate to establish a trial registry at the convenient places for a researcher.
[Note: Drug Act 2035 mentioned any person who intends to carry out a clinical trial of any new drug shall obtain a license from the department, as prescribed, for such trial. For conducting the clinical trial in Nepal, medicine registration guidance (Issued under Drug Registration Regulation 2038) section 2.18 mentions the approval of the Nepal Health Research Council (NHRC) and other government-approved agencies are required.]